These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 18991400)
21. Characterization of insulin/IGF hybrid receptors: contributions of the insulin receptor L2 and Fn1 domains and the alternatively spliced exon 11 sequence to ligand binding and receptor activation. Benyoucef S; Surinya KH; Hadaschik D; Siddle K Biochem J; 2007 May; 403(3):603-13. PubMed ID: 17291192 [TBL] [Abstract][Full Text] [Related]
22. Complementation analysis demonstrates that insulin cross-links both alpha subunits in a truncated insulin receptor dimer. Chan SJ; Nakagawa S; Steiner DF J Biol Chem; 2007 May; 282(18):13754-8. PubMed ID: 17339314 [TBL] [Abstract][Full Text] [Related]
23. Alanine scanning mutagenesis of the second extracellular loop of type 1 corticotropin-releasing factor receptor revealed residues critical for peptide binding. Gkountelias K; Tselios T; Venihaki M; Deraos G; Lazaridis I; Rassouli O; Gravanis A; Liapakis G Mol Pharmacol; 2009 Apr; 75(4):793-800. PubMed ID: 19124613 [TBL] [Abstract][Full Text] [Related]
24. Determination of residues important in hormone binding to the extracellular domain of the luteinizing hormone/chorionic gonadotropin receptor by site-directed mutagenesis and modeling. Bhowmick N; Huang J; Puett D; Isaacs NW; Lapthorn AJ Mol Endocrinol; 1996 Sep; 10(9):1147-59. PubMed ID: 8885249 [TBL] [Abstract][Full Text] [Related]
25. Leu 193 mutation in the cysteine rich region of the insulin receptor inhibits the cleavage of the insulin receptor precursor but not insulin binding. Takata Y; Imamura T; Haruta T; Egawa K; Takada Y; Sawa T; Yang GH; Kobayashi M Biochem Biophys Res Commun; 1994 Sep; 203(2):763-7. PubMed ID: 8093054 [TBL] [Abstract][Full Text] [Related]
26. Identification of the ligand-binding site of the BMP type IA receptor for BMP-4. Hatta T; Konishi H; Katoh E; Natsume T; Ueno N; Kobayashi Y; Yamazaki T Biopolymers; 2000; 55(5):399-406. PubMed ID: 11241215 [TBL] [Abstract][Full Text] [Related]
27. Site-Directed Mutagenesis of the Fibronectin Domains in Insulin Receptor-Related Receptor. Deyev IE; Chachina NA; Zhevlenev ES; Petrenko AG Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156593 [TBL] [Abstract][Full Text] [Related]
28. Direct determination of the insulin-insulin receptor interface using transferred cross-saturation experiments. Nakamura T; Takahashi H; Takahashi M; Shimba N; Suzuki E; Shimada I J Med Chem; 2010 Mar; 53(5):1917-22. PubMed ID: 20158183 [TBL] [Abstract][Full Text] [Related]
29. Insulin/receptor binding: the last piece of the puzzle? What recent progress on the structure of the insulin/receptor complex tells us (or not) about negative cooperativity and activation. De Meyts P Bioessays; 2015 Apr; 37(4):389-97. PubMed ID: 25630923 [TBL] [Abstract][Full Text] [Related]
30. Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists. Hoare SR; Sullivan SK; Schwarz DA; Ling N; Vale WW; Crowe PD; Grigoriadis DE Biochemistry; 2004 Apr; 43(13):3996-4011. PubMed ID: 15049707 [TBL] [Abstract][Full Text] [Related]
31. Mapping of alkali-sensing sites of the insulin receptor-related receptor. The role of L2 and fibronectin domains. Deyev IE; Chachina NA; Shayahmetova DM; Serova OV; Petrenko AG Biochimie; 2015 Apr; 111():1-9. PubMed ID: 25597417 [TBL] [Abstract][Full Text] [Related]
32. Deletion of V335 from the L2 domain of the insulin receptor results in a conformationally abnormal receptor that is unable to bind insulin and causes Donohue's syndrome in a human subject. George S; Johansen A; Soos MA; Mortensen H; Gammeltoft S; Saudek V; Siddle K; Hansen L; O'Rahilly S Endocrinology; 2003 Feb; 144(2):631-7. PubMed ID: 12538626 [TBL] [Abstract][Full Text] [Related]
33. A basic residue, Lys 782, composes part of the ATP-binding site on the epidermal growth factor receptor tyrosine kinase. Klingbeil CK; Gill GN Arch Biochem Biophys; 1999 Mar; 363(1):27-32. PubMed ID: 10049496 [TBL] [Abstract][Full Text] [Related]
34. Molecular interactions of nonpeptide agonists and antagonists with the melanocortin-4 receptor. Fleck BA; Chen C; Yang W; Huntley R; Markison S; Nickolls SA; Foster AC; Hoare SR Biochemistry; 2005 Nov; 44(44):14494-508. PubMed ID: 16262250 [TBL] [Abstract][Full Text] [Related]
35. Ligand-induced activation of the insulin receptor: a multi-step process involving structural changes in both the ligand and the receptor. Ward CW; Lawrence MC Bioessays; 2009 Apr; 31(4):422-34. PubMed ID: 19274663 [TBL] [Abstract][Full Text] [Related]
36. The insulin receptor: a prototype for dimeric, allosteric membrane receptors? De Meyts P Trends Biochem Sci; 2008 Aug; 33(8):376-84. PubMed ID: 18640841 [TBL] [Abstract][Full Text] [Related]
37. The insulin-binding domain of insulin receptor is encoded by exon 2 and exon 3. Yip CC J Cell Biochem; 1992 Jan; 48(1):19-25. PubMed ID: 1316357 [TBL] [Abstract][Full Text] [Related]
38. Importance of extracellular domains for ligand binding in the thyrotropin-releasing hormone receptor. Han B; Tashjian AH Mol Endocrinol; 1995 Dec; 9(12):1708-19. PubMed ID: 8614407 [TBL] [Abstract][Full Text] [Related]
39. Sequence gamma 377-395(P2), but not gamma 190-202(P1), is the binding site for the alpha MI-domain of integrin alpha M beta 2 in the gamma C-domain of fibrinogen. Ugarova TP; Lishko VK; Podolnikova NP; Okumura N; Merkulov SM; Yakubenko VP; Yee VC; Lord ST; Haas TA Biochemistry; 2003 Aug; 42(31):9365-73. PubMed ID: 12899623 [TBL] [Abstract][Full Text] [Related]